Labcorp
Search results
Labcorp Drug Development offers services in the preclinical, clinical and post-market phases of drug development, the product life cycles for medical device and diagnostics and development services paired with regulatory support for the chemical testing and crop protection industries.
From drug discovery to clinical trial testing and diagnostic development and commercialization, today’s Labcorp combines the innovations of more than five decades supporting our biopharma partners in bringing new therapies to patients.
Our global lab footprint, vast clinical data and scientific expertise help accelerate the drug development process.
Through our unparalleled diagnostics and drug development laboratory capabilities, our 60,000+ employees combine cutting-edge innovation, science and technology to solve some of today’s biggest health challenges, accelerate life-changing healthcare breakthroughs and impact lives around the world.
Save time and gain efficiency with a programmatic approach to drug development. Gain new insights with a prospective planning view that will advance you through the long and complex scientific and regulatory process to maximize the value of your asset.
Developing drugs and life-changing treatments starts here, with you. Before any new or improved drugs or treatments can be widely used, they must go through phases of testing to determine efficacy and ensure safety.
Spanning the drug development continuum. From drug discovery and nonclinical studies to central labs and companion diagnostics, we are your laboratory services partner. Our global lab network supports drug development in more than 100 countries, generating more clinical trial data than any other company. Learn More.
Apr 5, 2024 · No matter what therapeutic area or disease indication you’re developing for, you can tap into our extensive experience and get your pharmaceutical drug or medical device to the people who need it. We can help you test your therapeutic treatment throughout its entire lifecycle of development.
This transformation will enable Labcorp’s drug development business, Covance, a global leader in decentralized clinical trials (DCTs), to quickly and efficiently connect patients to clinical trials, which will allow for better access to potential drugs, vaccines, and medical devices.
Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers. With unparalleled diagnostics and drug development capabilities, we...
